3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine - CAS 90914-41-3
Catalog: |
BB055273 |
Product Name: |
3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine |
CAS: |
90914-41-3 |
Synonyms: |
3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; 1H-PYRAZOLO[3,4-D]PYRIMIDINE, 3-BROMO-4-CHLORO- |
IUPAC Name: | 3-bromo-4-chloro-2H-pyrazolo[3,4-d]pyrimidine |
Molecular Weight: | 233.45 |
Molecular Formula: | C5H2BrClN4 |
Canonical SMILES: | C1=NC2=NNC(=C2C(=N1)Cl)Br |
InChI: | InChI=1S/C5H2BrClN4/c6-3-2-4(7)8-1-9-5(2)11-10-3/h1H,(H,8,9,10,11) |
InChI Key: | MDFHFCAMBZNSLV-UHFFFAOYSA-N |
GHS Hazard Statement: | H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021123798-A1 | 1h-pyrazolo[3,4-d]pyrimidine compounds useful for the treatment of platinum-resistant cancer | 20191219 |
CN-110526921-B | Compound with anti-inflammatory effect and preparation method and application thereof | 20190807 |
TW-202023628-A | Novel cyclic dinucleotide derivatives and antibody-drug conjugates | 20180906 |
CN-112714649-A | Novel cyclic dinucleotide derivatives and antibody drug conjugates thereof | 20180906 |
BR-112021003472-A2 | cyclic dinucleotide derivative and antibody-drug conjugate thereof | 20180906 |
EP-3848054-A1 | Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof | 20180906 |
IL-281247-D0 | New derivatives of cyclic dinucleotides and their drug-antibody couplings | 20180906 |
JP-WO2020050406-A1 | New cyclic dinucleotide derivative and its antibody drug conjugate | 20180906 |
KR-20210057066-A | Novel Cyclic Dinucleotide Derivatives and Antibody Drug Conjugates | 20180906 |
US-2022008549-A1 | Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof | 20180906 |
Complexity: | 157 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 231.91514 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 231.91514 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 54.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS